Actuate Therapeutics Inc
USD1.53
-0.05 (-3.16%)
CEO
Daniel Schmitt
IPO Date
2024-08-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.61
Prev. Close
$1.58
Day Low
$1.46
Day High
$1.63
52W Low
$1.46
52W High
$9.22
Market Cap
$0.04B
Volume
0.12M
| -5.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 24.8% | -826.0% | 0.00 | 0.43 | -5.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -135.9% | -98.4% | 0.03 | 4.71 | -6.4 |
| -7.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -49.4% | -30.5% | 0.00 | 2.74 | -6.6 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 224.2% | -85.4% | 0.00 | 0.73 | -5.0 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 124.2% | -140.9% | 0.00 | 0.46 | -5.2 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -6187.1% | -69.2% | 0.00 | 1.05 | -6.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -111.4% | -41.9% | 0.00 | 1.68 | -6.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 5.8% | -379.7% | -0.06 | 0.03 | -6.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 7.7% | -307.4% | -0.05 | 0.15 | -4.0 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 7.6% | -254.1% | 0.00 | 0.43 | -4.3 |